CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells

Clinical and Experimental Immunology

Volumn 144, Issue 3, 2006, Pages 447-457

  Altvater, B ^a   Pscherer, S ^a   Landmeier, S ^a   Niggemeier, V ^a   Juergens, H ^a   Vormoor, J ^a   Rossig, C ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

CD28; Co stimulation; Epstein Barr virus; Immunotherapy; T cells

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GANGLIOSIDE GD2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; OKT 3; RECEPTOR; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHIMERA; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; STIMULATION; T LYMPHOCYTE ACTIVATION; TUMOR;

ANTIGENS, CD28; ANTIGENS, NEOPLASM; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 33744479956     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03095.x     Document Type: Article

References (49)

1. Bollard CM Aguilar L Straathof KC et al. Cytotoxic T lymphocyte therapy for Epstein-Barr-virus+ Hodgkin's disease. J Exp Med 2004 200 : 1623 33.
2. Dudley ME Wunderlich JR Robbins PF et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002 298 : 850 4.
3. Eshhar Z Waks T Gross G Schindler DG. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci USA 1993 90 : 720 4.
4. Rossig C Brenner MK. Genetic modification of T lymphocytes for adoptive immunotherapy. Mol Ther 2004 10 : 5 18.
5. Brentjens RJ Latouche JB Santos E et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med 2003 9 : 279 86.
6. Haynes NM Trapani JA Teng MWL et al. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 co-stimulation. J Immunol 2002 169 : 5780 6.
7. Hwu P Yang JC Cowherd R et al. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res 1995 55 : 3369 73.
8. Harding FA Mcarthur JG Gross JA Raulet DH Allison JP. Cd28-mediated signaling co-stimulates murine T-cells and prevents induction of anergy in T-cell clones. Nature 1992 356 : 607 9.
9. Brocker T Karjalainen K. Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes. J Exp Med 1995 181 : 1653 9.
10. Brocker T. Chimeric Fv-zeta or Fv-epsilon receptors are not sufficient to induce activation or cytokine production in peripheral T cells. Blood 2000 96 : 1999 2001.
11. Mitsuyasu RT Anton PA Deeks SG et al. Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects. Blood 2000 96 : 785 93.
12. Walker RE Bechtel CM Natarajan V et al. Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood 2000 96 : 467 74.
13. Lenschow DJ Walunas TL Bluestone JA. CD28/B7 system of T cell co-stimulation. Annu Rev Immunol 1996 14 : 233 58.
14. Friedmann-Morvinski D Bendavid A Waks T Schindler D Eshhar Z. Redirected primary T cells harboring a chimeric receptor require co-stimulation for their antigen-specific activation. Blood 2005 105 : 3087 93.
15. Finney HM Lawson AD Bebbington CR Weir AN. Chimeric receptors providing both primary and co-stimulatory signaling in T cells from a single gene product. J Immunol 1998 161 : 2791 7.
16. Geiger TL Nguyen P Leitenberg D Flavell RA. Integrated src kinase and co-stimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes. Blood 2001 98 : 2364 71.
17. Hombach A Wieczarkowiecz A Marquardt T et al. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 co-stimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule. J Immunol 2001 167 : 6123 31.
18. Maher J Brentjens RJ Gunset G Riviere I Sadelain M. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor. Nat Biotechnol 2002 20 : 70 5.
19. Rossig C Bollard CM Nuchtern JG Rooney CM Brenner MK. Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy. Blood 2002 99 : 2009 16.
20. Heemskerk MHM Hoogeboom M Hagedoorn R Willemze R Falkenburg JHF. Redirection of CMV-specific T-cells towards anti-leukaemic reactivity using T-cell receptor gene transfer. Bone Marrow Transplant 2004 33 : S21.
21. Rossig C Bollard CM Nuchtern JG Merchant DA Brenner MK. Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes. Int J Cancer 2001 94 : 228 36.
22. Riviere I Brose K Mulligan RC. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 1995 92 : 6733 7.
23. Kinsella TM Nolan GP. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996 7 : 1405 13.
24. Hanenberg H Xiao XL Dilloo D Hashino K Kato I Williams DA. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996 2 : 876 82.
25. Sen G Chakraborty M Foon KA Reisfeld RA BhattacharyaChatterjee M. Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2. Clin Cancer Res 1997 3 : 1969 76.
26. Betts MR Brenchley JM. Price DA et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Meth 2003 281 : 65 78.
27. Eshhar Z Waks T Bendavid A Schindler DG. Functional expression of chimeric receptor genes in human T cells. J Immunol Meth 2001 248 : 67 76.
28. Willemsen RA Ronteltap C Chames P Debets R Bolhuis RLH. T cell retargeting with MHC class I-restricted antibodies: the CD28 co-stimulatory domain enhances antigen-specific cytotoxicity and cytokine production. J Immunol 2005 174 : 7853 8.
29. Finney HM Akbar AN Lawson ADG. Activation of resting human primary T cells with chimeric receptors: co-stimulation from CD28, inducible co-stimulator, CD134, and CD137 in series with signals from the TCR zeta chain. J Immunol 2004 172 : 104 13.
30. Rossig C Bar A Pscherer S et al. Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors. J Immunotherapy 2006 29 : 21 31.
31. Dunne PJ Faint JM Gudgeon NH et al. Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 2002 100 : 933 40.
32. Wills MR Carmichael AJ Weekes MP et al. Human virus-specific CD8(+) CTL clones revert from CD45RO(high) to CD45RA(high) in vivo: CD45RA(high) CD8(+) T cells comprise both naive and memory cells. J Immunol 1999 162 : 7080 7.
33. Kershaw MH Westwood JA Hwu P. Dual-specific T cells combine proliferation and antitumor activity. Nat Biotechnol 2002 20 : 1221 7.
34. Appay V Dunbar PR Callan M et al. Memory CD8(+) T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002 8 : 379 85.
35. Powell DJ Dudley ME Robbins PF Rosenberg SA. Transition of late-stage effector T cells to CD27(+) CD28(+) tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 2005 105 : 241 50.
36. Sharpe AH Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002 2 : 116 26.
37. Dubey C Croft M Swain SL. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus co-stimulatory signals. J Immunol 1996 157 : 3280 9.
38. London CA Lodge MP Abbas AK. Functional responses and co-stimulator dependence of memory CD4(+) T cells. J Immunol 2000 164 : 265 72.
39. Schweitzer AN Sharpe AH. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J Immunol 1998 161 : 2762 71.
40. Topp MS Riddell SR Akatsuka Y Jensen MC Blattman JN Greenberg PD. Restoration of CD28 expression in CD28-CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production. J Exp Med 2003 198 : 947 55.
41. Janssen EM Lemmens EE Wolfe T Christen U von Herrath MG Schoenberger SP. CD4(+) T cells are required for secondary expansion and memory in CD8(+) T lymphocytes. Nature 2003 421 : 852 6.
42. Pule MA Straathof KC Dotti G Heslop HE Rooney CM Brenner MK. A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Mol Ther 2005 12 : 933 41.
43. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol 2003 3 : 609 20.
44. Bertram EM Lau P Watts TH. Temporal segregation of 4-1BB versus CD28-mediated co-stimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J Immunol 2002 168 : 3777 85.
45. Imai C Mihara K Andreansky M et al. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia 2004 18 : 676 84.
46. Hirano N Butler MO Nadler LM. 41BB, (CD137) or CD40 signaling fails to improve the expansion of antigen-specific T cells demonstrated with engagement of TCR, CD28 and CD83 ligand [Abstract]. Blood 104 : 2665.
47. Yamada A Salama AD Sho M et al. CD70 signaling is critical for CD28-independent CD8(+) T cell-mediated alloimmune responses in vivo. J Immunol 2005, 2004 174 : 1357 64.
48. Riddell SR Watanabe KS Goodrich JM Li CR Agha ME Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T-cell clones. Science 1992 257 : 238 41.
49. Rooney CM Smith CA Ng CYC et al. Use of gene-modified virus-specific T-lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995 345 : 9 13.